Your browser is no longer supported. Please, upgrade your browser.
ITRM Iterum Therapeutics plc daily Stock Chart
Iterum Therapeutics plc
Index- P/E- EPS (ttm)-6.75 Insider Own0.30% Shs Outstand14.87M Perf Week-4.24%
Market Cap23.94M Forward P/E- EPS next Y-2.17 Insider Trans-88.72% Shs Float11.18M Perf Month-22.07%
Income-98.70M PEG- EPS next Q-0.87 Inst Own41.90% Short Float3.44% Perf Quarter-59.79%
Sales0.00M P/S- EPS this Y-32.40% Inst Trans-15.24% Short Ratio0.34 Perf Half Y-71.89%
Book/sh-2.81 P/B- EPS next Y31.30% ROA-207.40% Target Price- Perf Year-82.98%
Cash/sh1.16 P/C0.98 EPS next 5Y- ROE848.60% 52W Range1.12 - 7.65 Perf YTD-74.89%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-85.23% Beta-
Dividend %- Quick Ratio0.60 Sales past 5Y- Gross Margin- 52W Low0.89% ATR0.12
Employees44 Current Ratio0.60 Sales Q/Q- Oper. Margin- RSI (14)30.00 Volatility5.38% 7.26%
OptionableNo Debt/Eq- EPS Q/Q24.80% Profit Margin- Rel Volume0.58 Prev Close1.13
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.15M Price1.13
Recom3.00 SMA20-17.71% SMA50-52.07% SMA200-60.76% Volume0 Change0.00%
Jun-02-20Downgrade RBC Capital Mkts Outperform → Sector Perform $7 → $2
Jan-21-20Downgrade Gabelli & Co Buy → Sell
Dec-11-19Downgrade SVB Leerink Outperform → Mkt Perform
Jun-21-19Initiated H.C. Wainwright Buy $17
Jul-13-20 04:05PM  
Jun-30-20 09:12AM  
Jun-29-20 07:30AM  
Jun-15-20 04:30PM  
Jun-03-20 03:45PM  
Jun-02-20 09:42AM  
Jun-01-20 08:30AM  
May-14-20 09:31AM  
Apr-09-20 04:05PM  
Mar-31-20 07:00AM  
Mar-12-20 06:45AM  
Feb-19-20 07:30AM  
Jan-17-20 06:15AM  
Jan-03-20 03:15PM  
Dec-26-19 05:00PM  
Dec-12-19 09:42AM  
Dec-11-19 07:21AM  
Dec-10-19 04:10PM  
Nov-30-19 10:18AM  
Nov-18-19 07:30AM  
Nov-12-19 07:05PM  
Nov-08-19 01:01PM  
Nov-06-19 10:30AM  
Oct-01-19 10:07AM  
Sep-27-19 04:30PM  
Sep-09-19 03:24PM  
Aug-14-19 08:15AM  
Aug-06-19 10:30AM  
Aug-01-19 07:30AM  
Jul-10-19 12:13PM  
Jul-01-19 09:13AM  
Jun-21-19 07:30AM  
Jun-20-19 11:13AM  
Jun-07-19 09:27AM  
May-14-19 07:00AM  
Apr-12-19 10:08AM  
Apr-11-19 07:30AM  
Mar-28-19 09:00AM  
Mar-25-19 07:00AM  
Mar-19-19 07:00AM  
Feb-21-19 10:15AM  
Feb-19-19 07:30AM  
Jan-17-19 10:00AM  
Dec-20-18 12:36PM  
Nov-14-18 07:15AM  
Nov-05-18 04:05PM  
Oct-05-18 08:00AM  
Sep-25-18 04:05PM  
Sep-20-18 08:00AM  
Sep-18-18 08:00AM  
Aug-14-18 07:30AM  
Aug-09-18 04:05PM  
Jun-06-18 10:08AM  
May-25-18 12:51AM  
May-24-18 08:15PM  
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a novel penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum Therapeutics plc was founded in 2015 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sofinnova Venture Partners IX,10% OwnerJun 02Sale1.61400,000642,9601,226,514Jun 03 08:20 PM
Sofinnova Venture Partners IX,10% OwnerJun 01Sale1.69100,000169,1201,626,514Jun 03 08:20 PM